These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1598074)

  • 1. Presence of methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines, derivatives of the neurotoxin isoquinoline, in parkinsonian lumbar CSF.
    Moser A; Kömpf D
    Life Sci; 1992; 50(24):1885-91. PubMed ID: 1598074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presence of N-methyl-norsalsolinol in the CSF: correlations with dopamine metabolites of patients with Parkinson's disease.
    Moser A; Scholz J; Nobbe F; Vieregge P; Böhme V; Bamberg H
    J Neurol Sci; 1995 Aug; 131(2):183-9. PubMed ID: 7595645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of 2-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline and 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, novel endogenous amines, in parkinsonian and normal human brains.
    Niwa T; Takeda N; Yoshizumi H; Tatematsu A; Yoshida M; Dostert P; Naoi M; Nagatsu T
    Biochem Biophys Res Commun; 1991 Jun; 177(2):603-9. PubMed ID: 2049084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-methyl-norsalsolinol, an endogenous neurotoxin, inhibits tyrosine hydroxylase activity in the rat brain nucleus accumbens in vitro.
    Scholz J; Bamberg H; Moser A
    Neurochem Int; 1997 Dec; 31(6):845-9. PubMed ID: 9413846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of N-methyl-norsalsolinol on monoamine oxidase of the rat caudate nucleus in vitro.
    Moser A; Scholz J; Bamberg H; Böhme V
    Neurochem Int; 1996 Jan; 28(1):109-12. PubMed ID: 8746770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxins: 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 1,2,3,4-tetrahydroisoquinoline and 1-methyl-6,7-dihydroxy-tetrahydroisoquinoline as substrates for FAD-containing monooxygenase of porcine liver microsomes.
    Wu RF; Miura S; Ichikawa Y
    Biochem Pharmacol; 1992 Nov; 44(10):2079-81. PubMed ID: 1449525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in salsolinol level in the cerebrospinal fluid of parkinsonian patients is related to dementia: advantage of a new high-performance liquid chromatography methodology.
    Antkiewicz-Michaluk L; Krygowska-Wajs A; Szczudlik A; Romańska I; Vetulani J
    Biol Psychiatry; 1997 Sep; 42(6):514-8. PubMed ID: 9285087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Salsolinol, 3-O-methyl-dopa and homovanillic acid in the cerebrospinal fluid of Parkinson patients].
    Krygowska-Wajs A; Szczudlik A; Antkiewicz-Michaluk L; Romańska I; Vetulani J
    Neurol Neurochir Pol; 1997; 31(5):875-85. PubMed ID: 9513952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigro-striatal system of the human brain.
    Maruyama W; Sobue G; Matsubara K; Hashizume Y; Dostert P; Naoi M
    Neurosci Lett; 1997 Feb; 223(1):61-4. PubMed ID: 9058423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Presence of tetrahydroisoquinoline and 2-methyl-tetrahydroquinoline in parkinsonian and normal human brains.
    Niwa T; Takeda N; Kaneda N; Hashizume Y; Nagatsu T
    Biochem Biophys Res Commun; 1987 Apr; 144(2):1084-9. PubMed ID: 3579928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of rodent brain monoamine oxidase and tyrosine hydroxylase by endogenous compounds - 1,2,3,4-tetrahydro-isoquinoline alkaloids.
    Patsenka A; Antkiewicz-Michaluk L
    Pol J Pharmacol; 2004; 56(6):727-34. PubMed ID: 15662085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
    Naoi M; Dostert P; Yoshida M; Nagatsu T
    Adv Neurol; 1993; 60():212-7. PubMed ID: 8420137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: in vivo microdialysis study.
    Maruyama W; Nakahara D; Ota M; Takahashi T; Takahashi A; Nagatsu T; Naoi M
    J Neurochem; 1992 Aug; 59(2):395-400. PubMed ID: 1629715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives.
    Minami M; Maruyama W; Dostert P; Nagatsu T; Naoi M
    J Neural Transm Gen Sect; 1993; 92(2-3):125-35. PubMed ID: 8369106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase.
    Naoi M; Matsuura S; Parvez H; Takahashi T; Hirata Y; Minami M; Nagatsu T
    J Neurochem; 1989 Feb; 52(2):653-5. PubMed ID: 2911035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoquinoline neurotoxins in the brain and Parkinson's disease.
    Nagatsu T
    Neurosci Res; 1997 Oct; 29(2):99-111. PubMed ID: 9359458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
    Kajita M; Niwa T; Fujisaki M; Ueki M; Niimura K; Sato M; Egami K; Naoi M; Yoshida M; Nagatsu T
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):345-51. PubMed ID: 7581910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regional distribution of tetrahydroisoquinoline derivatives in rodent, human, and Parkinson's disease brain.
    DeCuypere M; Lu Y; Miller DD; LeDoux MS
    J Neurochem; 2008 Dec; 107(5):1398-413. PubMed ID: 19013830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type A monoamine oxidase is the target of an endogenous dopaminergic neurotoxin, N-methyl(R)salsolinol, leading to apoptosis in SH-SY5Y cells.
    Yi H; Akao Y; Maruyama W; Chen K; Shih J; Naoi M
    J Neurochem; 2006 Jan; 96(2):541-9. PubMed ID: 16336631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.